Extensive toxic epidermal necrolysis following brentuximab vedotin administration

Ann Hematol. 2015 Feb;94(2):355-6. doi: 10.1007/s00277-014-2148-3. Epub 2014 Jul 2.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Brentuximab Vedotin
  • Diagnosis, Differential
  • Humans
  • Immunoconjugates / administration & dosage
  • Immunoconjugates / adverse effects*
  • Male
  • Skin / drug effects*
  • Skin / pathology
  • Stevens-Johnson Syndrome / diagnosis*
  • Stevens-Johnson Syndrome / etiology
  • Young Adult

Substances

  • Immunoconjugates
  • Brentuximab Vedotin